Computational Drug Design Systems is categorized under Website Design Services in Rockville, MD and active since 2011.
Computational Drug Design Systems was established in 2011, and today employs 1 to 4, earning $50.000 to $99.999 per year. This is a Website Design Services business, which does work in the B2B market, and is classified as a Website Design Services, under code number 541512 by the NAICS.
If you are seeking more information, feel free to contact Iwona Weidlich at the company’s single location by writing to 243 Rollins Avenue Apartment 104, Rockville, Maryland MD 20852 or by phoning (240) 409-2467. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Computational Drug Design Systems |
| Contact Person: | Iwona Weidlich |
| Address: | 243 Rollins Avenue Apartment 104, Rockville, Maryland 20852 |
| Phone Number: | (240) 409-2467 |
| Annual Revenue (USD): | $50.000 to $99.999 |
| Founded: | 2011 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2B (Business to Business) |
| Business Category: | Website Design Services |
| SIC Code: | 7373 |
| NAICS Code: | 541512 |
| Share This Business: |
Computational Drug Design Systems was started in 2011 to provide professional Website Design Services under the SIC code 7373 and NAICS code 541512. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $50.000 to $99.999 per annum.
Feel free to contact Iwona Weidlich for inquiries that concern Computational Drug Design Systems by calling the company number (240) 409-2467, as your correspondence is most welcome. Additionally, the physical location of the single location of Computational Drug Design Systems can be found at the coordinates 39.058606,-77.126941 as well as the street address 243 Rollins Avenue Apartment 104 in Rockville, Maryland 20852.
For its online presence, you may visit Computational Drug Design Systems’s website at and engage with its social media outlets through on Twitter and on Facebook.